Browse Studies — Arctuva

Phase 3

A Phase III Randomised, Double-Blind, Placebo-Controlled Multicentre Trial to Evaluate the Efficacy and Safety of AZD6234 as an Adjunct to Incretin-based Therapies in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity With or Without Type 2 Diabetes Mellitus (SELENE 3)

The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in p…

Obesity or OverweightWeight-Related ComorbidityWith/Without Diabetes Mellitus, Type 2

Estimated

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT07776509

Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities: A Pilot Study of the Patient Priorities Care Approach at Cooper Green Mercy Health Services Authority (PPC-HEART)

This is formative evaluation trial guided by the Values Clarification Theory25 and the Cultural Values Theory26, with specific aims to: Aim 1. Develop a cultur…

CardiovascularComorbidityDiabetes+4 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Alabama at BirminghamNCT07748858

Observational

Project COMET: Hybrid Effectiveness-Implementation Trial of Massed PTSD Treatment in a Community Substance Use Program

The goal of this clinical trial is to learn if Massed Prolonged Exposure Therapy (M-PE) can improve PTSD symptoms and reduce substance use in adults receiving …

Posttraumatic Stress Disorder (PTSD)Substance Use Disorders (SUD)Comorbidity+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Rutgers, The State University of New JerseyNCT06968832